Nutrition and adult inflammatory bowel disease

  title={Nutrition and adult inflammatory bowel disease},
  author={J. C. B. Goh and Colin O'morain},
  journal={Alimentary Pharmacology \& Therapeutics},
  • J. Goh, C. O'morain
  • Published 1 February 2003
  • Medicine
  • Alimentary Pharmacology & Therapeutics
Major advances in the understanding of the aetio‐pathogenesis and genetics of inflammatory bowel disease have been accompanied by an escalation in the sophistication of immunomodulatory inflammatory bowel disease therapeutics. However, the basic ‘triple’ therapy (5‐aminosalicylates, corticosteroids, azathioprine) and nutrition have maintained their central role in the management of patients with inflammatory bowel disease over recent decades. 
Infliximab reverses growth hormone resistance associated with inflammatory bowel disease
This work has shown that inflammation plays a major role in the aetiology of catabolism and wasting observed in inflammatory bowel disease via growth hormone resistance and will help clarify the role of EMT in this disease.
New nutritional approach to inflammatory bowel disease: the nutraceuticals
A high compliance and a statistically significant improvement of symptoms, nutritional status, inflammatory index and Crohn’s disease activity index are observed among enteral formula enriched in specific nutraceuticals used in IBD.
Nutritional Aspects in Inflammatory Bowel Diseases
The nutritional assessment for inflammatory bowel disease patients should include a dietetic evaluation with the assessment of daily caloric intake and energy expenditure, radiological assessment, and measurement of functional capacity.
Nutritional Therapy for Inflammatory Bowel Disease
Besides exclusive enteral nutrition as a potential first-line treatment in active Crohn’s disease, other nutritional therapeutic modalities such as partialEnteral nutrition, parenteral nutrition, diets based on carbohydrate modifications, anti-inflam matory diet, and the use of specific dietary compounds with anti-inflammatory proper - ties, known as pharmaconutrition are presented.
Advances in Nutrition of Patients with Inflammatory Bowel Diseases
The present paper is to present simply review and analyse of recent reports regarding nutrition in patients with CD and UC as well as to discuss recommended nutritional management in certain IBD course-associated conditions.
Dietary Management in Pediatric Patients with Crohn’s Disease
A synopsis of the available nutritional strategies in the management of pediatric CD is provided and their application in the dietary management of these patients is discussed.
Enteral nutrition decreases hospitalization rate in patients with Crohn's disease
Enteral nutrition with an elemental diet plays an important role in the treatment for CD patients in Japan, because of its few adverse effects, and is thought to be effective in maintaining remission.
The utilization of parenteral nutrition during the in‐patient management of inflammatory bowel disease in the United States: a national survey
Parenteral nutrition has a limited role in the in‐patient management of inflammatory bowel disease and the use of these nutrients should not be considered as a substitute for conventional therapies.
The use of enteral nutrition in the management of Crohn's disease in adults.
  • X. Dray, P. Marteau
  • Medicine, Biology
    JPEN. Journal of parenteral and enteral nutrition
  • 2005
Results are presented of studies performed with antioxidants, glutamine, short-chain fatty acids, prebiotics, probiotics, low microparticle diets, and a TGFbeta2 enriched formulation on enteral nutrition in adults with Crohn's disease.